“Express Scripts (ESRX) has been reiterated by TheStreet Ratings as a buy with a ratings score of B . The company’s strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels, increase in net income and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.”
,” the firm’s analyst commented.
Shares of Express Scripts traded down 0.47% during mid-day trading on Wednesday, hitting $54.84. Express Scripts has a one year low of $49.79 and a one year high of $66.06. The stock’s 50-day moving average is currently $54.55. The company has a market cap of $44.771 billion and a P/E ratio of 32.97.
A number of other firms have also recently commented on ESRX. Analysts at Raymond James reiterated an outperform rating on shares of Express Scripts in a research note to investors on Tuesday. They now have a $62.00 price target on the stock. Separately, analysts at Zacks downgraded shares of Express Scripts from a neutral rating to an underperform rating in a research note to investors on Tuesday, January 29th. They now have a $49.00 price target on the stock. Finally, analysts at Lazard Capital Markets reiterated a buy rating on shares of Express Scripts in a research note to investors on Tuesday, January 29th. They now have a $64.00 price target on the stock.
Fifteen investment analysts have rated the stock with a buy rating, one has issued an overweight rating, and three have given a hold rating to the stock. The stock currently has a consensus rating of buy and an average target price of $63.10.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.